• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丝氨酸蛋白酶抑制剂纤溶酶原激活物抑制剂2型的C-D螺旋间结构域是免受肿瘤坏死因子-α诱导的细胞凋亡所必需的。

The C-D interhelical domain of the serpin plasminogen activator inhibitor-type 2 is required for protection from TNF-alpha induced apoptosis.

作者信息

Dickinson J L, Norris B J, Jensen P H, Antalis T M

机构信息

Queensland Cancer Fund Experimental Oncology Unit, The Queensland Institute of Medical Research, Brisbane, 4029, Australia.

出版信息

Cell Death Differ. 1998 Feb;5(2):163-71. doi: 10.1038/sj.cdd.4400324.

DOI:10.1038/sj.cdd.4400324
PMID:10200461
Abstract

The serine proteinase inhibitor (serpin), plasminogen activator inhibitor type 2 (PAI-2), has been reported to inhibit tumor necrosis factor-alpha (TNF) induced apoptosis. In order to begin to understand the molecular basis for this protection, we have investigated the importance of a structural domain within the PAI-2 molecule, the C-D interhelical region, in mediating the protective effect. The C-D interhelical region is a 33 amino acid insertion which is unique among serpins and has been implicated in transglutaminase catalyzed cross-linking of PAI-2 to cell membranes. We have constructed a mutant of PAI-2 wherein 23 amino acids are deleted from the C-D interhelical region generating a structure predicted to be homologous to the closely related, but non-inhibitory serpin, chicken ovalbumin. The PAI-2Delta65/87 deletion mutant retained inhibitory activity against its known serine proteinase target, urokinase-type plasminogen activator (uPA); however expression of this mutant in HeLa cells failed to protect from TNF-induced apoptosis. Analyses of the cellular distribution of PAI-2 showed that intracellular PAI-2, and not secreted or cell-surface PAI-2, was likely responsible for the observed protection from TNF-induced apoptosis. No evidence was found for specific cross-linking of PAI-2 to the plasma membrane in either control or TNF/cycloheximide treated cells. The data demonstrate that the PAI-2 C-D interhelical domain is functionally important in PAI-2 protection from TNF induced apoptosis and suggest a novel function for the C-D interhelical domain in the protective mechanism.

摘要

丝氨酸蛋白酶抑制剂(丝氨酸蛋白酶抑制剂),纤溶酶原激活物抑制剂2型(PAI-2),已被报道可抑制肿瘤坏死因子-α(TNF)诱导的细胞凋亡。为了开始理解这种保护作用的分子基础,我们研究了PAI-2分子内一个结构域,即C-D螺旋间区域,在介导保护作用中的重要性。C-D螺旋间区域是一个33个氨基酸的插入片段,在丝氨酸蛋白酶抑制剂中是独特的,并且与转谷氨酰胺酶催化的PAI-2与细胞膜的交联有关。我们构建了一个PAI-2突变体,其中从C-D螺旋间区域删除了23个氨基酸,产生了一种预测与密切相关但无抑制作用的丝氨酸蛋白酶抑制剂鸡卵清蛋白同源的结构。PAI-2Delta65/87缺失突变体对其已知的丝氨酸蛋白酶靶点尿激酶型纤溶酶原激活物(uPA)仍保留抑制活性;然而,该突变体在HeLa细胞中的表达未能保护细胞免受TNF诱导的凋亡。对PAI-2细胞分布的分析表明,细胞内的PAI-2而非分泌型或细胞表面的PAI-2可能是观察到的免受TNF诱导凋亡保护作用的原因。在对照细胞或TNF/环己酰亚胺处理的细胞中均未发现PAI-2与质膜特异性交联的证据。数据表明,PAI-2的C-D螺旋间结构域在PAI-2保护细胞免受TNF诱导凋亡中具有重要功能,并提示C-D螺旋间结构域在保护机制中具有新功能。

相似文献

1
The C-D interhelical domain of the serpin plasminogen activator inhibitor-type 2 is required for protection from TNF-alpha induced apoptosis.丝氨酸蛋白酶抑制剂纤溶酶原激活物抑制剂2型的C-D螺旋间结构域是免受肿瘤坏死因子-α诱导的细胞凋亡所必需的。
Cell Death Differ. 1998 Feb;5(2):163-71. doi: 10.1038/sj.cdd.4400324.
2
Plasminogen activator inhibitor-2 is highly tolerant to P8 residue substitution--implications for serpin mechanistic model and prediction of nsSNP activities.纤溶酶原激活物抑制剂-2对P8残基取代具有高度耐受性——对丝氨酸蛋白酶抑制剂机制模型及单核苷酸多态性(nsSNP)活性预测的启示
J Mol Biol. 2005 Nov 11;353(5):1069-80. doi: 10.1016/j.jmb.2005.09.008. Epub 2005 Sep 22.
3
Analysis of serpin inhibitory function by mutagenesis of ovalbumin and generation of chimeric ovalbumin/PAI-2 fusion proteins.通过卵清蛋白诱变和嵌合卵清蛋白/PAI-2融合蛋白的生成分析丝氨酸蛋白酶抑制剂的抑制功能。
J Mol Biol. 1997 Apr 4;267(3):561-9. doi: 10.1006/jmbi.1996.0909.
4
Identification of interaction between PAI-2 and IRF-3.纤溶酶原激活物抑制剂-2(PAI-2)与干扰素调节因子-3(IRF-3)之间相互作用的鉴定。
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2003 Jul;35(7):661-5.
5
Binding areas of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex for endocytosis receptors of the low-density lipoprotein receptor family, determined by site-directed mutagenesis.通过定点诱变确定尿激酶型纤溶酶原激活剂-纤溶酶原激活剂抑制剂-1复合物与低密度脂蛋白受体家族内吞作用受体的结合区域。
FEBS J. 2006 Nov;273(22):5143-59. doi: 10.1111/j.1742-4658.2006.05511.x. Epub 2006 Oct 17.
6
The undecided serpin. The ins and outs of plasminogen activator inhibitor type 2.未明确的丝氨酸蛋白酶抑制剂。纤溶酶原激活物抑制剂2的来龙去脉
FEBS J. 2005 Oct;272(19):4858-67. doi: 10.1111/j.1742-4658.2005.04879.x.
7
Differential mechanisms of plasminogen activator inhibitor-1 gene activation by transforming growth factor-beta and tumor necrosis factor-alpha in endothelial cells.转化生长因子-β和肿瘤坏死因子-α在内皮细胞中激活纤溶酶原激活物抑制剂-1基因的不同机制。
Thromb Haemost. 2001 Dec;86(6):1563-72.
8
Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha-induced apoptosis. Evidence for an alternate biological function.2型纤溶酶原激活物抑制剂抑制肿瘤坏死因子α诱导的细胞凋亡。关于一种替代生物学功能的证据。
J Biol Chem. 1995 Nov 17;270(46):27894-904. doi: 10.1074/jbc.270.46.27894.
9
Evidence for serpinB2-independent protection from TNF-alpha-induced apoptosis.不依赖丝氨酸蛋白酶抑制剂B2对肿瘤坏死因子-α诱导的细胞凋亡产生保护作用的证据。
Exp Cell Res. 2006 Feb 1;312(3):350-61. doi: 10.1016/j.yexcr.2005.11.003. Epub 2005 Dec 5.
10
Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells.肿瘤坏死因子-α和曲格列酮通过细胞外信号调节激酶和核因子-κB依赖的途径调控培养的人脐静脉内皮细胞中1型纤溶酶原激活物抑制剂的产生。
J Pharmacol Exp Ther. 2003 Dec;307(3):987-94. doi: 10.1124/jpet.103.054346. Epub 2003 Oct 8.

引用本文的文献

1
The transcription factor C/EBP-β mediates constitutive and LPS-inducible transcription of murine SerpinB2.转录因子 C/EBP-β 介导鼠 SerpinB2 的组成型和 LPS 诱导型转录。
PLoS One. 2013;8(3):e57855. doi: 10.1371/journal.pone.0057855. Epub 2013 Mar 5.
2
TANK-binding kinase 1 (TBK1) controls cell survival through PAI-2/serpinB2 and transglutaminase 2.TANK 结合激酶 1(TBK1)通过 PAI-2/丝氨酸蛋白酶抑制剂 B2 和转谷氨酰胺酶 2 控制细胞存活。
Proc Natl Acad Sci U S A. 2012 Jan 24;109(4):E177-86. doi: 10.1073/pnas.1119296109. Epub 2011 Dec 27.
3
Association of plasminogen activator inhibitor type 2 (PAI-2) with proteasome within endothelial cells activated with inflammatory stimuli.
炎症刺激激活的内皮细胞中纤溶酶原激活物抑制剂 2(PAI-2)与蛋白酶体的关联。
J Biol Chem. 2011 Dec 16;286(50):43164-71. doi: 10.1074/jbc.M111.245647. Epub 2011 Oct 5.
4
Mycobacterium tuberculosis blocks crosslinking of annexin-1 and apoptotic envelope formation on infected macrophages to maintain virulence.结核分枝杆菌阻断膜联蛋白-1的交联以及感染巨噬细胞上凋亡包膜的形成,以维持毒力。
Nat Immunol. 2008 Oct;9(10):1189-97. doi: 10.1038/ni.1654. Epub 2008 Sep 14.
5
Analysis of vertebrate genomes suggests a new model for clade B serpin evolution.脊椎动物基因组分析为B族丝氨酸蛋白酶抑制剂的进化提出了一种新模型。
BMC Genomics. 2005 Nov 23;6:167. doi: 10.1186/1471-2164-6-167.
6
The ovalbumin serpins revisited: perspective from the chicken genome of clade B serpin evolution in vertebrates.重新审视卵清蛋白丝氨酸蛋白酶抑制剂:从鸡基因组看脊椎动物B族丝氨酸蛋白酶抑制剂的进化视角
Proc Natl Acad Sci U S A. 2005 Aug 9;102(32):11367-72. doi: 10.1073/pnas.0502934102. Epub 2005 Jul 29.
7
Silencing of integrated human papillomavirus type 18 oncogene transcription in cells expressing SerpinB2.在表达丝氨酸蛋白酶抑制剂B2的细胞中,整合的人乳头瘤病毒18型致癌基因转录的沉默
J Virol. 2005 Apr;79(7):4246-56. doi: 10.1128/JVI.79.7.4246-4256.2005.
8
Maspin mediates increased tumor cell apoptosis upon induction of the mitochondrial permeability transition.在诱导线粒体通透性转变后,乳腺丝抑蛋白介导肿瘤细胞凋亡增加。
Mol Cell Biol. 2005 Mar;25(5):1737-48. doi: 10.1128/MCB.25.5.1737-1748.2005.
9
A hybrid protein of the amino-terminal fragment of urokinase and mutant plasminogen activator inhibitor-2 efficiently inhibits tumor cell invasion and metastasis.尿激酶氨基末端片段与突变型纤溶酶原激活物抑制剂-2的杂合蛋白可有效抑制肿瘤细胞的侵袭和转移。
J Cancer Res Clin Oncol. 2005 Feb;131(2):129-36. doi: 10.1007/s00432-004-0623-2. Epub 2004 Oct 12.
10
Inhibition of retinoblastoma protein degradation by interaction with the serpin plasminogen activator inhibitor 2 via a novel consensus motif.通过一个新的共有基序与丝氨酸蛋白酶抑制剂纤溶酶原激活物抑制剂2相互作用来抑制视网膜母细胞瘤蛋白降解。
Mol Cell Biol. 2003 Sep;23(18):6520-32. doi: 10.1128/MCB.23.18.6520-6532.2003.